Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio -9-MTH group results

Jan 29 (Reuters)-  
             Takara Bio Inc.  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended       Year to  
                Dec 31, 2015        Dec 31, 2014     Mar 31, 2016  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             20.71               17.29            29.20     
                 (+19.7 pct)         (+7.0 pct)       (+12.4 pct)  
  Operating          1.44                1.26             2.45     
                 (+14.4 pct)         (+39.1 pct)      (+6.4 pct)   
  Recurring          1.70                1.38             3.00     
                 (+22.6 pct)         (+39.6 pct)      (+8.2 pct)   
  Net              613 mln           loss 84 mln          1.40     
                                                      (+45.2 pct)  
  EPS             5.10 yen          loss 0.71 yen      11.63 yen   
  Ann Div                             1.50 yen         1.50 yen    
  -Q2 div            NIL                 NIL                       
  -Q4 div                             1.50 yen         1.50 yen    
   
  NOTE - Takara Bio Inc..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Takara Bio

See all news